← FDA DRUG APPROVALS

FDA ANDA · ANDA040174

LEUCOVORIN CALCIUM

Sponsor: TEVA PHARMS USA

APPLICATION
ANDA040174
TYPE
ANDA
ORIGINAL APPROVAL
1997-06-12
LATEST ACTION
2013-04-29
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

LEUCOVORIN CALCIUMDiscontinued
LEUCOVORIN CALCIUM EQ 350MG BASE/VIAL · INJECTABLE · INJECTION

Approval history

2013-04-29Labeling · Supplement 18 · standardAP
2011-09-06Labeling · Supplement 6AP
1998-12-16Labeling · Supplement 2AP
1998-04-28Labeling · Supplement 1AP
1997-06-12OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →